Coronavirus Notebook: Moderna Postpones EU Spikevax Supplies, Industry Insists TRIPS Waiver Is Redundant
The medical NGO, MSF, has urged countries not to adopt the latest draft of the proposed waiver, saying it would impair efforts to boost access to COVID-19 products around the world. The WHO has been looking at the benefits of hybrid immunity – and how far it might be waning.
You may also be interested in...
The controversial “TRIPS waiver” is high on the agenda of the World Trade Organization’s upcoming ministerial conference, while a working group of the World Health Organization is drawing up a draft pandemic treaty that includes proposals to weaken IP on pandemic countermeasures.
The World Health Organization’s plan to have a global pandemic treaty in place by 2024 is drawing a lot of attention as work continues to produce a working draft by the middle of the year.
As work continues on vaccines adapted to tackle variants of SARS-CoV-2, the EU regulator says the decision-making on such products should take place at a global level.